Skip to main content
Clinical Trials/NCT04587869
NCT04587869
Terminated
Not Applicable

Still Climbin': A Randomized Controlled Trial to Improve Coping, Medical Mistrust, and Healthcare Engagement Among Black Sexual Minority Men

RAND1 site in 1 country369 target enrollmentFebruary 9, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Discrimination, Social
Sponsor
RAND
Enrollment
369
Locations
1
Primary Endpoint
Inadequate Healthcare Utilization
Status
Terminated
Last Updated
5 months ago

Overview

Brief Summary

This study consists of a randomized controlled trial of a multi-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Primary intervention objectives include increasing health care engagement and receipt of evidence-based preventive care, as well as better coping and reduced anticipated and internalized stigma, and medical mistrust among intervention participants.

Detailed Description

This study is a randomized controlled trial of Still Climbin', an 8-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Designed to be flexible for use in community settings, this intervention was developed in partnership with community stakeholders who emphasized the need for a community-based program outside of the health care system, and without a specific disease focus. It intends to give Black SMM a safe space to receive support for the whole of their identity and to openly discuss barriers to health care. Participants will be followed for 12 months. The effectiveness of the Still Climbin' intervention will be assessed on health care engagement and receipt of evidence-based preventive care, through surveys administered at multiple points throughout the intervention period. These outcomes will be confirmed with information from medical records. A total of 370 Black participants will be recruited and randomly assign 185 to receive the coping intervention and 185 to a no-treatment control. There will be about 10 groups of about 15 participants each for both intervention and control. Participants will be randomized to an intervention or control group after they complete the baseline survey. Participants will complete four surveys, starting with the baseline survey, and followed by 4-, 8-, and 12-month post-baseline follow-up surveys to assess health care engagement and receipt of evidence-based preventive care (e.g., cancer and diabetes screening, cardiovascular disease prevention, influenza vaccination, HIV prevention), and other topics such as coping strategies, stigma, and discrimination. The intervention is hypothesized to show increased health care engagement and receipt of evidence-based preventive care, in addition to better coping and reduced medical mistrust than the control group.

Registry
clinicaltrials.gov
Start Date
February 9, 2021
End Date
March 20, 2025
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
RAND
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Biologically male at birth
  • Identify as male
  • Self-identify as a Black/African American
  • Report having sex with men in the past 24 months
  • Anticipate being available for the next 12 months to attend study visits
  • Able to interact and communicate in written and spoken English.

Exclusion Criteria

  • Unwilling/Unable to provide informed consent
  • Cisgender women
  • Transgender women
  • Transgender men

Outcomes

Primary Outcomes

Inadequate Healthcare Utilization

Time Frame: baseline to 12-month post-baseline

Indicator that the individual reported (1) fewer than 1 ambulatory visit AND (2) at least 1 emergency department visit (without subsequent hospitalization) or at least 1 hospitalization in the past 4 months at any of the 3 follow-up assessments (4, 8, and 12 months post-baseline)

Proportion of Evidence-based Care Components Received Across Follow-up Assessments

Time Frame: baseline to 12 months post-baseline

For each individual, this measure is the number of components that were received at any time across the 3 follow-up assessments divided by the number of components they were eligible for at any time across the 3 follow-up assessments, expressed as a proportion. 25 components were evaluated and eligibility for each component varies by individual and follow-up period.

Secondary Outcomes

  • Adaptive Coping Strategies (Social Support Seeking)(4-, 8-, and 12-months post-baseline)

Study Sites (1)

Loading locations...

Similar Trials